IBDEI14R ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20190,0)
 ;;=625.6^^115^1223^1
 ;;^UTILITY(U,$J,358.3,20190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20190,1,3,0)
 ;;=3^625.6
 ;;^UTILITY(U,$J,358.3,20190,1,4,0)
 ;;=4^Female Stress Incontinence
 ;;^UTILITY(U,$J,358.3,20190,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,20191,0)
 ;;=788.31^^115^1223^8
 ;;^UTILITY(U,$J,358.3,20191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20191,1,3,0)
 ;;=3^788.31
 ;;^UTILITY(U,$J,358.3,20191,1,4,0)
 ;;=4^Urge Incontinence
 ;;^UTILITY(U,$J,358.3,20191,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,20192,0)
 ;;=788.33^^115^1223^6
 ;;^UTILITY(U,$J,358.3,20192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20192,1,3,0)
 ;;=3^788.33
 ;;^UTILITY(U,$J,358.3,20192,1,4,0)
 ;;=4^Mixed Incontinence (M)(F)
 ;;^UTILITY(U,$J,358.3,20192,2)
 ;;=^293936
 ;;^UTILITY(U,$J,358.3,20193,0)
 ;;=599.70^^115^1223^2
 ;;^UTILITY(U,$J,358.3,20193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20193,1,3,0)
 ;;=3^599.70
 ;;^UTILITY(U,$J,358.3,20193,1,4,0)
 ;;=4^Hematuria NOS
 ;;^UTILITY(U,$J,358.3,20193,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,20194,0)
 ;;=599.71^^115^1223^3
 ;;^UTILITY(U,$J,358.3,20194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20194,1,3,0)
 ;;=3^599.71
 ;;^UTILITY(U,$J,358.3,20194,1,4,0)
 ;;=4^Hematuria, Gross
 ;;^UTILITY(U,$J,358.3,20194,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,20195,0)
 ;;=599.72^^115^1223^4
 ;;^UTILITY(U,$J,358.3,20195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20195,1,3,0)
 ;;=3^599.72
 ;;^UTILITY(U,$J,358.3,20195,1,4,0)
 ;;=4^Hematuria, Microscopic
 ;;^UTILITY(U,$J,358.3,20195,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,20196,0)
 ;;=795.00^^115^1224^4
 ;;^UTILITY(U,$J,358.3,20196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20196,1,3,0)
 ;;=3^795.00
 ;;^UTILITY(U,$J,358.3,20196,1,4,0)
 ;;=4^Abnormal Pap
 ;;^UTILITY(U,$J,358.3,20196,2)
 ;;=^328609
 ;;^UTILITY(U,$J,358.3,20197,0)
 ;;=626.8^^115^1224^30
 ;;^UTILITY(U,$J,358.3,20197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20197,1,3,0)
 ;;=3^626.8
 ;;^UTILITY(U,$J,358.3,20197,1,4,0)
 ;;=4^Dysfunctional Bleeding
 ;;^UTILITY(U,$J,358.3,20197,2)
 ;;=^87521
 ;;^UTILITY(U,$J,358.3,20198,0)
 ;;=628.9^^115^1224^44
 ;;^UTILITY(U,$J,358.3,20198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20198,1,3,0)
 ;;=3^628.9
 ;;^UTILITY(U,$J,358.3,20198,1,4,0)
 ;;=4^Female Infertility Nos
 ;;^UTILITY(U,$J,358.3,20198,2)
 ;;=^62820
 ;;^UTILITY(U,$J,358.3,20199,0)
 ;;=610.1^^115^1224^45
 ;;^UTILITY(U,$J,358.3,20199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20199,1,3,0)
 ;;=3^610.1
 ;;^UTILITY(U,$J,358.3,20199,1,4,0)
 ;;=4^Fibrocystic Breast
 ;;^UTILITY(U,$J,358.3,20199,2)
 ;;=^46167
 ;;^UTILITY(U,$J,358.3,20200,0)
 ;;=V10.3^^115^1224^49
 ;;^UTILITY(U,$J,358.3,20200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20200,1,3,0)
 ;;=3^V10.3
 ;;^UTILITY(U,$J,358.3,20200,1,4,0)
 ;;=4^Hx Of Breast Cancer
 ;;^UTILITY(U,$J,358.3,20200,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,20201,0)
 ;;=V10.43^^115^1224^50
 ;;^UTILITY(U,$J,358.3,20201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20201,1,3,0)
 ;;=3^V10.43
 ;;^UTILITY(U,$J,358.3,20201,1,4,0)
 ;;=4^Hx Of Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,20201,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,20202,0)
 ;;=611.72^^115^1224^56
 ;;^UTILITY(U,$J,358.3,20202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20202,1,3,0)
 ;;=3^611.72
 ;;^UTILITY(U,$J,358.3,20202,1,4,0)
 ;;=4^Lump Or Mass In Breast
 ;;^UTILITY(U,$J,358.3,20202,2)
 ;;=^72018
 ;;^UTILITY(U,$J,358.3,20203,0)
 ;;=625.9^^115^1224^72
 ;;^UTILITY(U,$J,358.3,20203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20203,1,3,0)
 ;;=3^625.9
 ;;^UTILITY(U,$J,358.3,20203,1,4,0)
 ;;=4^Pelvic Pain
